Objective: Targeted drug delivery can concentrate drugs at the lesion site and selectively kill lesion cells. Folate receptors have limited expression in human healthy cells but are over-expressing on the surface of cancer cells. Our study decided to develop one of site-specific intracellular delivery against the folate receptor. Methods: First, poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA were synthesized according to respective reaction routes and were confirmed by 1H nuclear magnetic resonance (1H NMR) and infrared spectroscopy (IR). Second, busulfan was selected as drug model and loaded into the carriers by self-assembly. The cytotoxicity of poly-β-CD-PEG-OCH3, busulfan loaded poly-β-CD-PEG-OCH3, poly-β-CD-PEG-FA and busulfan loaded poly-β-CD-PEG-FA was determined by a crystal violet stain assay. Last, The potential of poly-β-CD-PEG-FA for use in the targeting delivery of busulfan was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis in HepG2, which contain folate receptors on its surfaces. Results: poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA were successfully synthesized and proved by 1H NMR and IR. Busulfan was successfully loaded into poly β-CD-PEG-FA and poly β-CD-PEG-OCH3 and their content are 3.379 mg/g and 3.548 mg/g, respectively. Poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA with the concentration between 12.5-50 μg/ml had no effect on cell survival rate of HepG2 cells but with over 100 μg/ml had a significant inhibitory effect. The MTT results revealed that in HepG2 cells, the cytotoxicity of poly-β-CD-PEG-FA loaded busulfan cells is greater than that of poly-β-CD-PEG-OCH3 loaded busulfan. Conclusion: Poly-β-CD-PEG-FA can be used as a carrier for hydrophobic anticancer chemotherapeutic drugs. After being loaded into poly-β-CD-PEG-FA, busulfan still maintained its original anticancer activity and had obvious targeted drug delivery effect on tumor cells with folate receptor over-expression.
| Published in | Journal of Drug Design and Medicinal Chemistry (Volume 9, Issue 2) |
| DOI | 10.11648/j.jddmc.20230902.11 |
| Page(s) | 16-22 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Busulfan, Poly-β-Cyclodextrin, Folate, Targeted Delivery, Cancer
| [1] | Xu N, Hua Z, Ba, G, et al. The anti-tumor growtheffect of a novel agentdmamcl in rhabdomyosarcoma in vitro and in vivo. J. Exp. Clin. Cancer. Res 2019; 38, 118. |
| [2] | Asmawi A. A, Salim N, NganC. L, et al. Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded withdocetaxel for lung cancer treatment. Drug Deliv. Transl. Res2019; 9: 543–554. |
| [3] | Panda J, Satapathy B. S, Majumder S et al. Engineered polymeric iron oxidenanoparticles as potential drug carrier for targeted delivery of docetaxel to breast cancer cells. J. Magn. Magn. Mater 2019, 485: 165–173. |
| [4] | Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug 1989; 6: 193–210. |
| [5] | Moku G, Layek B, Trautman L, et al. Improving payload capacity andanti-tumor efficacy of mesenchymal stem cells using tat peptide functionalized polymeric nanoparticles. Cancers 2019; 11, 491. |
| [6] | Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci. 1997; 86: 147–62. |
| [7] | Szejtli J, Cyclolab BH. Chemistry, physical and biological propertiers of cyclodextrin. Comprehensive Supramolecular Chemistry, 1996, 3: 5–40. |
| [8] | Zhang X, Niu S, Williams G. R, et al. Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy. Carbohydr. Polym 2019; 221: 84–93. |
| [9] | Zhang Q, Deng S, Liu J, et al. Cancer-targeting graphemequantumdots: Fluorescence quantum yields, stability, and cell selectivity. Adv. Funct. Mater2019; 29. |
| [10] | Narmani A, Rezvani M, Farhood B, et al. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug Dev. Res. 2019; 80: 404–424. |
| [11] | Yaoyao L, Jiahui Peng, NingLi, et al. Smart nanoparticles assembled by endogenous molecules for siRNA delivery and cancer therapy via CD44 and EGFR dual-targeting. Nanomedicine: Nanotechnology, Biology and Medicine 2019; 15: 208–217. |
| [12] | Meredith A, JacksonSean K. Bedingfield, Fang Yu, et al. Dual carrier-cargo hydrophobization and charge ratio optimization improve the systemic circulation and safety of zwitterionic nano-polyplexes. Biomaterials 2019; 192: 245–259. |
| [13] | Guangyong Zhu, Guangxu Zhu, Zuobing Xiao. A review of the production of slow release flavor by formationinclusion complex with cyclodextrins and their derivatives. Journal of Inclusion Phenomena and Macrocyclic Chemistry2019; 95: 17–33. |
| [14] | Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: 1. Drug solubilisation and stabilization. J Pharm Sci1996; 85: 1017–25. |
| [15] | Szetjli J. Introduction and general overview of cyclodextrin chemistry. Chem Rev 1998; 98: 1743–53. |
| [16] | Simone Braga Carneiro, Fernanda Ílary Costa Duarte, Luana Heimfarth, et al. Cyclodextrin–Drug Inclusion Complexes: In Vivo andIn Vitro Approaches. International Journal ofMolecular Sciences 2019, 20 (3), 642–665. |
| [17] | HoonH yun, Sungsu Lee, WonbongLim, et al. Engineered beta-cyclodextrin-based carrier for targeted doxorubicin delivery in breast cancer therapy in vivo2019, 70 (25): 145–151. |
APA Style
Xin Li, Xin Zhang. (2023). Preparation and Characterization of Targeted Drug Carrier Materials Poly-β-Cyclodextrin-PEG-Folate Acid. Journal of Drug Design and Medicinal Chemistry, 9(2), 16-22. https://doi.org/10.11648/j.jddmc.20230902.11
ACS Style
Xin Li; Xin Zhang. Preparation and Characterization of Targeted Drug Carrier Materials Poly-β-Cyclodextrin-PEG-Folate Acid. J. Drug Des. Med. Chem. 2023, 9(2), 16-22. doi: 10.11648/j.jddmc.20230902.11
AMA Style
Xin Li, Xin Zhang. Preparation and Characterization of Targeted Drug Carrier Materials Poly-β-Cyclodextrin-PEG-Folate Acid. J Drug Des Med Chem. 2023;9(2):16-22. doi: 10.11648/j.jddmc.20230902.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jddmc.20230902.11,
author = {Xin Li and Xin Zhang},
title = {Preparation and Characterization of Targeted Drug Carrier Materials Poly-β-Cyclodextrin-PEG-Folate Acid},
journal = {Journal of Drug Design and Medicinal Chemistry},
volume = {9},
number = {2},
pages = {16-22},
doi = {10.11648/j.jddmc.20230902.11},
url = {https://doi.org/10.11648/j.jddmc.20230902.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jddmc.20230902.11},
abstract = {Objective: Targeted drug delivery can concentrate drugs at the lesion site and selectively kill lesion cells. Folate receptors have limited expression in human healthy cells but are over-expressing on the surface of cancer cells. Our study decided to develop one of site-specific intracellular delivery against the folate receptor. Methods: First, poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA were synthesized according to respective reaction routes and were confirmed by 1H nuclear magnetic resonance (1H NMR) and infrared spectroscopy (IR). Second, busulfan was selected as drug model and loaded into the carriers by self-assembly. The cytotoxicity of poly-β-CD-PEG-OCH3, busulfan loaded poly-β-CD-PEG-OCH3, poly-β-CD-PEG-FA and busulfan loaded poly-β-CD-PEG-FA was determined by a crystal violet stain assay. Last, The potential of poly-β-CD-PEG-FA for use in the targeting delivery of busulfan was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis in HepG2, which contain folate receptors on its surfaces. Results: poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA were successfully synthesized and proved by 1H NMR and IR. Busulfan was successfully loaded into poly β-CD-PEG-FA and poly β-CD-PEG-OCH3 and their content are 3.379 mg/g and 3.548 mg/g, respectively. Poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA with the concentration between 12.5-50 μg/ml had no effect on cell survival rate of HepG2 cells but with over 100 μg/ml had a significant inhibitory effect. The MTT results revealed that in HepG2 cells, the cytotoxicity of poly-β-CD-PEG-FA loaded busulfan cells is greater than that of poly-β-CD-PEG-OCH3 loaded busulfan. Conclusion: Poly-β-CD-PEG-FA can be used as a carrier for hydrophobic anticancer chemotherapeutic drugs. After being loaded into poly-β-CD-PEG-FA, busulfan still maintained its original anticancer activity and had obvious targeted drug delivery effect on tumor cells with folate receptor over-expression.},
year = {2023}
}
TY - JOUR T1 - Preparation and Characterization of Targeted Drug Carrier Materials Poly-β-Cyclodextrin-PEG-Folate Acid AU - Xin Li AU - Xin Zhang Y1 - 2023/07/11 PY - 2023 N1 - https://doi.org/10.11648/j.jddmc.20230902.11 DO - 10.11648/j.jddmc.20230902.11 T2 - Journal of Drug Design and Medicinal Chemistry JF - Journal of Drug Design and Medicinal Chemistry JO - Journal of Drug Design and Medicinal Chemistry SP - 16 EP - 22 PB - Science Publishing Group SN - 2472-3576 UR - https://doi.org/10.11648/j.jddmc.20230902.11 AB - Objective: Targeted drug delivery can concentrate drugs at the lesion site and selectively kill lesion cells. Folate receptors have limited expression in human healthy cells but are over-expressing on the surface of cancer cells. Our study decided to develop one of site-specific intracellular delivery against the folate receptor. Methods: First, poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA were synthesized according to respective reaction routes and were confirmed by 1H nuclear magnetic resonance (1H NMR) and infrared spectroscopy (IR). Second, busulfan was selected as drug model and loaded into the carriers by self-assembly. The cytotoxicity of poly-β-CD-PEG-OCH3, busulfan loaded poly-β-CD-PEG-OCH3, poly-β-CD-PEG-FA and busulfan loaded poly-β-CD-PEG-FA was determined by a crystal violet stain assay. Last, The potential of poly-β-CD-PEG-FA for use in the targeting delivery of busulfan was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis in HepG2, which contain folate receptors on its surfaces. Results: poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA were successfully synthesized and proved by 1H NMR and IR. Busulfan was successfully loaded into poly β-CD-PEG-FA and poly β-CD-PEG-OCH3 and their content are 3.379 mg/g and 3.548 mg/g, respectively. Poly β-CD-PEG-OCH3 and poly β-CD-PEG-FA with the concentration between 12.5-50 μg/ml had no effect on cell survival rate of HepG2 cells but with over 100 μg/ml had a significant inhibitory effect. The MTT results revealed that in HepG2 cells, the cytotoxicity of poly-β-CD-PEG-FA loaded busulfan cells is greater than that of poly-β-CD-PEG-OCH3 loaded busulfan. Conclusion: Poly-β-CD-PEG-FA can be used as a carrier for hydrophobic anticancer chemotherapeutic drugs. After being loaded into poly-β-CD-PEG-FA, busulfan still maintained its original anticancer activity and had obvious targeted drug delivery effect on tumor cells with folate receptor over-expression. VL - 9 IS - 2 ER -
Information
Email: